7/22/2020143 Listed Chinese MedPharm Cos Report H1 Performance

7/22/2020JW Therapeutics Buys Hong Kong Anti-cancer Drug Maker Syracuse Biophar...

7/22/2020China Oncology Drugs Market - Growth Opportunities Created by Covid-19...

7/22/2020NMPA Announces OTC Switch of Two Prescription Drugs

7/22/2020China Prepares for the Third Batch of National Volume-based Procuremen...

7/21/2020NMPA Issues Announcement for Applicability of ICH E2C(R2)

7/21/2020Shionogi Finalizes JV with Ping An Insurance in Shanghai

7/20/2020BeiGene and Assembly Bio Ink $540M China HBV Deal

7/20/2020NMPA Accepts Deciphera's NDA Submission of Ripretinib for Advanced GI ...

7/20/2020CDE Issues the Clinical Research Guidelines for Rituximab Biosimilar

7/20/2020CDE Issues the Clinical Research Guidelines for Trastuzumab Biosimilar...

7/20/2020CDE Issues the Guideline on the Submission of Clinical Trial Data

7/20/2020NHC and SATCM Issues Provisions for Administration of Medical Consorti...

7/19/2020Recent Executive Moves

7/19/2020Ascletis Completes Bridging Study In China For NASH Drug Candidate ASC...

7/19/2020Sunshine Guojian Seeks to Raise $248M in STAR Market IPO

7/19/2020RTW, Ji Xing Pharma and Cytokinetics Enter Strategic Financing Deal fo...

7/19/2020Antengene Closes $97M Series C Financing

7/17/2020Snapshot of Chinese Non-prescription Drug Market 2016-2019

7/17/2020IQVIA: Shanghai Drug Market Growth Up Substantially in 2019

7/17/2020NHSA Publishes 2019 National Basic Medical Insurance Sector Developmen...

7/17/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...

7/16/2020New Draft Patent Law - What To Expect and What Not to Expect

7/16/2020Chinese Hospital Drug Market Down 21.6% in Q1/2020: IQVIA

7/16/2020Novo Nordisk and CR Sanjiu Tie Up to Co-promote Norditropin in China

7/16/2020CDE Solicits Comments on the Draft Technical Guidelines for Clinical T...

7/16/2020AnHeart Out-licenses Korean Rights of Taletrectinib to NewG Lab

7/16/2020EIU: 2/3 of Rare Disease Patients in Asia-Pacific Do Not Receive the B...

7/16/2020LintonPharm Approved for Phase 3 Trial Evaluating Catumaxomab in Advan...

7/16/2020BioAtla Raises $72.5M in Series D Financing

Page:244/790 Total number of articles:23678: [First][<<] [242] [243] [244] [245] [246] [>>] [End]